Human cryptosporidiosis: A review

East African Medical Journal

Volumn 86, Issue 2, 2009, Pages 89-93

  Ayuo, P O ^a  

^a MOI UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; COCCIDIOSTATIC AGENT; NITAZOXANIDE; PAROMOMYCIN; SPIRAMYCIN; THIAZOLE DERIVATIVE;

ANIMAL; CLASSIFICATION; CRYPTOSPORIDIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; PARASITOLOGY; PROGNOSIS;

AMEBICIDES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; CLASSIFICATION; COCCIDIOSTATS; CRYPTOSPORIDIOSIS; HIV INFECTIONS; HUMANS; KENYA; PAROMOMYCIN; PROGNOSIS; SPIRAMYCIN; THIAZOLES;

EID: 70449109860     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v86i2.46941     Document Type: Review

References (56)

1. 1. Xiao, L., Fayer, R., Ryan, U. and Upton, S. J. Cryptosporidium taxonomy: Recent advances and implications for Public Health. Clin. Micro. Rev. 2004; 17: 72-97. (Pubitemid 38120930)
2. 2. Matos, O., Alves, M., Xiao, L., Cama, V. and Antunes, F. Cryptosporidium felis and C. meleagridis in persons with HIV, Portugal. Emerg. Infect. Dis. 2004; 10: 2256-2257. (Pubitemid 39587363)
3. Smith, H. V. and Corcoran, G. D. New drugs and treatment for cryptosporidiosis. Curr. Opin. Infect. Dis. 2004: 17: 557-564.
4. Caceio, S.M. Molecular epidemiology of human cryptosporidiosis. Parassitologia. 2005; 47: 185-192.
5. 5. Trotz-Williams, L. A., Martin, D. S., Gatei, W., et al. Genotype and subtype analyses of Cryptosporidium isolates from dairy calves and humans in Ontario. Parasitol. Res. 2006; 99: 346-352. (Pubitemid 44426723)
6. 6. Bern, C., Hernandez, B., Lopez, M.B., et al. The contrasting epidemiology of Cyclospora and Cryptosporidium among outpatients in Guatemala. Am. J. Trop. Med. Hyg. 2000; 63: 231-235. (Pubitemid 32537555)
7. 7. Adjei, A. A., Armah, H., Rodrigues, O., et al. Cryptosporidium Spp., a frequent cause of diarrhoea among children at the Korle-Bu Teaching Hospital, Accra, Ghana. Japan. J. Infect. Dis. 2004; 57: 216-219. (Pubitemid 39545702)
8. Kosek, M., Alcantara, C., Lima, A. A. and Guerrant, R. L. Cryptosporidiosis: an update. Lancet. Infect. Dis. 2001; 1: 261-269.
9. 9. Gatei, W., Wamae, C. N., Mbae, C, et al. Cryptosporidiosis: Prevalence, genotype analysis, and symptoms associated with infections in children in Kenya. Am. J. Trop. Med. Hyg. 2006; 75: 78-82. (Pubitemid 351627574)
10. Tumwine, J. K., Kekitiinwa, A., Bakeera-Kitaka, S., et al. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhoea with and without concurrent infection with HIV. Am. J. Trop. Med. Hyg. 2005; 73: 921-925.
11. Nell, M.A., Rice, S. K., Ahmad, N.V. and Flanigan, T. P. Cryptosporidiosis: an unrecognized cause of diarrhoea in elderly hospitalized patients. Clin. Infect. Dis. 1996; 27: 108-170.
12. Tangerman, R. H., Gordon, S., Wiesman, P. and Kreckma, L. An outbreak of Cryptosporidiosis in a day care centre in Georgia. Am. J. Epidem. 1991; 133: 471-476.
13. Miron, D., Kenes, J. and Dagan, R. Calves as a source of an outbreak of Cryptosporidiosis among young childrenin an agricultural closed community. Paediatr Infect. Dis. J. 1991; 10: 438-441.
14. Gallaher, M. M., Herndon, J. L., Nims, L. J., et al. Cryptosporidiosis and surface water. Am. J. Public Health 1989; 79: 39-42.
15. Xiao, L. and Herd, R. P. Epidemiology of equine Cryptosporidium and Giardia infections. Equine Vet. J. 1994; 26: 14-17.
16. 16. Sargent, K. D., Morgan, U. M., Elliot, A. and Andrew Thomson, R. C. Morphological and genetic characterization of Cryptosporidium oocysts from domestic cats. Vet. Parasitol. 1998; 77: 221-227. (Pubitemid 28408624)
17. Rickard, L. G., Siefker, C., Boyle, C. R. and Gentz, E. J. The prevalence of Cryptosporidium and Giardia spp in faecal samples from free ranging white tailed deer (Odocoileus virginianus) in the Southern United States. J. Vet. Diagn. Invest. 1999; 11: 65-72.
18. Suleiman, I. M., Xiao, L., Yang, C., et al. Differentiation of human from animal isolates of Cryptosporidium parvum. Emerg. Infect. Dis. 1998; 4: 681-685.
19. 19. McLauchlin, J., Amar, C., Pedraza-Diaz, S. and Nichols, G.L. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. J. Clin. Micro. 2000; 38: 3984-3990. (Pubitemid 32233193)
20. Laubach, H.E., Bentley, C. Z., Ginter, E. L., Spalter, J. S. and Jensen, L. A. A study of risk factors associated with the prevalence of Cryptosporidium in villages around Lake Atitlan, Guatemala. Braz. J. Infect. Dis. 2004; 8: 319-323.
21. Chacin-Bonilla, L., Panunzio, A. P., Monsal ve-Castillo, F. M., et al. Microsporidiosis in Venezuela: prevalence of intestinal microsporidiosis and its contribution to diarrhea in a group of human immunodeficiency virus-infected patients from Zulia State. Am. J. Trop. Med. Hyg. 2006; 74: 482-486.
22. Mwachari, C., Batchelor, B. I., Paul, J., et al. Chronic diarrhoea among HIV infected adult patients in Nairobi, Kenya. J. Infect. 1998; 37: 48-53.
23. Chokephaibulkit, K., Wanachiwanawin, D., Tosasuk, K., et al. Intestinal parasitic infections among human immunodeficiency virus- infected and -uninfected children hospitalized with diarrhoea in Bangkok, Thailand. Southeast. Asian. J. Trop. Med. Pub. Health. 2001; 32: 770-775.
24. 24. Hunter, P. R. and Nichols, G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 2002; 15: 145-154. (Pubitemid 34052587)
25. Navin, T. R., Weber, R., Vugia, D. J., et al. Declining CD4+ T -lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhoea: results of a 3 year longitudinal study. J. Acquired Immune Defic. Syndr. 1999; 20: 154-159.
26. 26. Pedersen, C., Danner, S., Lazzarani, A., et al. Epidemiology of Cryptosporidiosis among European AIDS patients. Genitourin. Med. 1996; 72: 128-131. (Pubitemid 26130429)
27. Sorvilo, F.J., Lieb, L. E., Kerndt, P. R. and Ash, L. R. Epidemiology of cryptosporidiosis among patients with AIDS in Los Angeles County. Am. J. Trop. Med. Hyg. 1994; 51: 326-331.
28. Glaser, C. A., Safrin, S., Reingold, A. and Newman, T.B.Association between Cryptosporidium infection and animal exposure in HIV infected individuals. J. Acquired Immun. Defic. Syndr. 1998; 17: 79-82.
29. Blanshard, C., Jackson, A. M., Shenson, D. C., Francis, N. and Gazzard, B. G. Cryptosporidiosis in HIV sero positive patients. Q. J. Med. 1992; 85: 813-823.
30. 30. Manabe, Y. C., Clark, D. P., Moore, R. D., et al. Cryptosporidiosis in patients with AIDS. Correlates of disease and survival. Clin. Infec. Dis. .1998; 27: 536-542. (Pubitemid 28422004)
31. 31. McGowan, I., Hawkins, A. S. and Weller, I. V. The natural history of Cryptosporidial diarrhoea in HIV infected patients. AIDS. 1993; 7: 349-354. (Pubitemid 23104550)
32. Colford, J. M., Jr., Tager, I. B., Hirozawa, A. M., et al. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am. J. Epidemiol 1996; 144: 807-816.
33. Goodgame, R. W. Understanding intestinal sporeforming protozoa: Cryptosporidia, Microsporidia, Isospora and Cyclospora. Annals. Intern. Med. 1996; 124: 429-441.
34. Ramirez, N. E., Ward, L. A. and Sreevatsan, S. A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes and Infection. 2004; 6: 773-785.
35. Kaushik, K., Khurana, S., Wanchu, A. and Malla, N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta. Trop. 2008; 107: 1-7.
36. Nielsen, C. K. and Ward, L. A. Enhanced detection of Cryptosporidium parvum in the acid- fast stain. J. Vet. Diagn. Invest. 1999; 11: 567-569.
37. Garcia, L. S. and Shimizu, R. Y. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol 1997; 35: 1526-1529.
38. el-Shazly, A. M., Gabr, A., Mahmoud, M. S., Aziz, S. S. and Saleh, W. A. The use of Ziehl-Neelsen stain, enzyme-linked immunosorbent assay and nested polymerase chain reaction in diagnosis of cryptosporidiosis in immuno-competent, compromised patients. J. Egypt. Soc. Parasitol. 2002; 32: 155-166.
39. da Silva, A. J., Bornay-Llinares, F.J., Moura, I. N., et al. Fast and reliable extraction of protozoan parasite DNA from fecal specimens. Mol. Diagn. 1999; 4: 57-64.
40. Mead, J. Cryptosporidiosis and the challenges of chemotherapy. Drug Resist Update. 2002; 5: 47-57.
41. 41. White, A. C. Jr, Chappell, C. L., Hayat, C. S., et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J. Infect. Dis. 1994; 170: 419-424. (Pubitemid 24226373)
42. Hewitt, R. G., Yiannoutsos, C.T., Higgs, E.S., et al. AIDS Clinical Trial Group. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. Clin. Infect. Dis. 2000; 31: 1084-1092.
43. Blagbum, B. and Soave, R. Prophylaxis and chemotherapy: human and animal. In:Fayer R, editor. Cryptosporidium and cryptosporidiosis. Boca Raton, FL: CRC Press; 1997. pp. 111-128.
44. 44. Kadappu, K. K., Nagaraja, M.V., Rao, P. V. and Shastry, B. A. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J. Postgrad Med. 2002; 48: 179-181. (Pubitemid 35386072)
45. Allam, A. F. and Shehab, A. Y. Efficacy of azithromycin, praziquantel and mirazid in treatment of cryptosporidiosis in school children. J. Egypt. Soc. Parasitol. 2002; 32: 969-978.
46. 46. Trad, O., Jumaa, P., Uduman, S. and Nawaz, A. Eradication of Cryptosporidium in four children with acute lymphoblastic leukaemia. J. Trop. Paed. 2003; 49: 128-130. (Pubitemid 36503744)
47. 47. Blanshard, C., Shanson, D. and Gazzard, B. Pilot studies of azithromycin, letazuril and paromomycin in the treatment of cryptosporidiosis. Int. J. STD. AIDS 1997; 8: 124-129. (Pubitemid 27086795)
48. Dunne, M., Williams, D. and Young, L. Azithromycin and the treatment of opportunistic infections. Rev. Contemp. Pharmacother. 1994; 5: 373-378.
49. Jordan, E. Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS. J. Natl. Med. Assoc. 1996; 100: 370-372.
50. Fichtenbaum, C. J., Zackin, R., Feinberg, J., Benson, C and Griffiths, J. K. AIDS Clinical Trials Group New Works Concept Sheet Team 064. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS. 2000; 14: 2889-2893.
51. 51. Sprinz, E., Mallman, R., Barcellos, S., et al. AIDS related cryptosporidial diarrhoea: an open study with roxithromycin. J. Antimicrob. Chemother. 1998; 41 (Suppl B): 85-91. (Pubitemid 28152230)
52. 52. Amadi, B., Mwiya, M., Musuku, J., et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002; 360: 1375-1380. (Pubitemid 35341302)
53. 53. Rossignol, J.F., Hidalgo, H., Feregrino, M., et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans. R. Soc. Trop. Med. Hyg. 1998; 92: 663-666. (Pubitemid 29015224)
54. Fox, L. M. and Saravolatz, L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 2005; 40: 1173-1180.
55. Wiwanitkit, V. Intestinal parasite infestation in HIV infected patients. Curr. HIV Res. 2006; 4: 87-96.
56. Dillingham, R. A., Lima, A. A. and Guerrant, R. L. Cryptosporidiosis: epidemic and impact. Microbes and Infect. 2002; 4: 1059-1066.